Johnson & Johnson
NYSE:JNJ

Watchlist Manager
Johnson & Johnson Logo
Johnson & Johnson
NYSE:JNJ
Watchlist
Price: 156.12 USD 1.07% Market Closed
Market Cap: 376.2B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+11%
Revenue
Forecast
+4%
Operating Income
Forecast
+13%
Net Income
Forecast
+27%

Wall Street
Price Targets

JNJ Price Targets Summary
Johnson & Johnson

Wall Street analysts forecast JNJ stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JNJ is 174.05 USD with a low forecast of 151.5 USD and a high forecast of 194.25 USD.

JNJ Lowest Forecast
Wall Street Target
151.5 USD
3% Downside
JNJ Average Forecast
Wall Street Target
174.05 USD
11% Upside
JNJ Highest Forecast
Wall Street Target
194.25 USD
24% Upside
Lowest
Price Target
151.5 USD
3% Downside
Average
Price Target
174.05 USD
11% Upside
Highest
Price Target
194.25 USD
24% Upside
Johnson & Johnson Competitors:
Price Targets
TARS
Tarsus Pharmaceuticals Inc
48% Upside
T
TORNTPHARM
Torrent Pharmaceuticals Ltd
10% Upside
D
DPHARMA
Duopharma Biotech Bhd
27% Upside
PFE
Pfizer Inc
23% Upside
TARS
Tarsus Pharmaceuticals Inc
48% Upside
T
TORNTPHARM
Torrent Pharmaceuticals Ltd
10% Upside
D
DPHARMA
Duopharma Biotech Bhd
27% Upside
PFE
Pfizer Inc
23% Upside

Revenue
Forecast

Revenue Estimate
Johnson & Johnson

For the last 8 years the compound annual growth rate for Johnson & Johnson's revenue is 3%. The projected CAGR for the next 3 years is 4%.

3%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-7%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Johnson & Johnson

For the last 8 years the compound annual growth rate for Johnson & Johnson's operating income is 1%. The projected CAGR for the next 3 years is 13%.

1%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-23%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Johnson & Johnson

For the last 8 years the compound annual growth rate for Johnson & Johnson's net income is -2%. The projected CAGR for the next 3 years is 27%.

-2%
Past Growth
27%
Estimated Growth
Estimates Accuracy
-26%
Average Miss
What are analyst estimates?

See Also

Summary
JNJ intrinsic value, competitors valuation, and company profile.
DCF Valuation
JNJ stock valuation using Discount Cash Flow valuation method.
Relative Valuation
JNJ stock valuation using valuation multiples.
Wall Street Estimates
JNJ price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
JNJ stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is JNJ's stock price target?
Price Target
174.05 USD

According to Wall Street analysts, the average 1-year price target for JNJ is 174.05 USD with a low forecast of 151.5 USD and a high forecast of 194.25 USD.

What is Johnson & Johnson's Revenue forecast?
Projected CAGR
4%

For the last 8 years the compound annual growth rate for Johnson & Johnson's revenue is 3%. The projected CAGR for the next 3 years is 4%.

What is Johnson & Johnson's Operating Income forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for Johnson & Johnson's operating income is 1%. The projected CAGR for the next 3 years is 13%.

What is Johnson & Johnson's Net Income forecast?
Projected CAGR
27%

For the last 8 years the compound annual growth rate for Johnson & Johnson's net income is -2%. The projected CAGR for the next 3 years is 27%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 252,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.